# Apocus, Inc.

Apocus, Inc. is a peptide provider in San Antonio, Texas, United States. See its services and where its facts come from.

FDA-registered 503B human drug compounding outsourcing facility in San Antonio, Texas.

## Details

- Address: San Antonio, Texas
- Phone: [214-797-7172](<tel:2147977172>)
- Services offered: Sterile compounding
- Pharmacy type: 503B outsourcing facility (FDA-registered)
- How the licence was checked: FDA 503B outsourcing facility register
- Licence to verify: FDA 503B registered outsourcing facility; initial registration 2023-10-17, most recent registration 2026-01-01
- Source of this row's facts: FDA registered outsourcing facilities table, current as of 2026-09-30, retrieved 2026-10-20

## Questions

### Where is Apocus, Inc.?

Apocus, Inc. is at San Antonio, Texas.

### How do I contact Apocus, Inc.?

To contact Apocus, Inc., call 214-797-7172.

### How do I check the licence of Apocus, Inc.?

This page says where the licence claim came from. Look it up on the named state board, the FDA 503B register or the NPI registry before you book — licence data can go out of date. If a fact looks wrong, write to hello@peptideclinic.fyi and we will check it.

## Source

From [US Food and Drug Administration, registered outsourcing facilities under section 503B](https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities), license Public domain (work of the US federal government), checked 2026-10-21.

Last updated October 21, 2026.

## Links

- This peptide provider on the [web page](<https://peptideclinic.fyi/texas/san-antonio/apocus-inc>)
- [Peptide therapy providers in San Antonio](<https://peptideclinic.fyi/texas/san-antonio/category/peptide-therapy-providers.md>)
- [Compounding pharmacies in San Antonio](<https://peptideclinic.fyi/texas/san-antonio/category/compounding-pharmacies.md>)
- [More peptide providers in San Antonio](<https://peptideclinic.fyi/texas/san-antonio.md>)

> **Not medical advice.** Regulatory status, checked 2026-10-20: FDA rules on the bulk substances a compounding pharmacy may use are in flux. A February 2026 HHS announcement moved about 14 peptides back toward the FDA Category 1 list, and sources disagree on the final status — check the FDA bulk-substances page (https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding) before you act. PeptideClinic is a directory, not a clinic or a pharmacy: a listing is a record, never an endorsement. It gives no dosing, no medical advice and no outcome claims, and it never lists research-chemical sellers. Confirm a provider's licence on the named state board, the FDA 503B register or the NPI registry before you book. In an emergency call 911.
